Skip to main content
. 2018 Jan 10;192(1):120–128. doi: 10.1111/cei.13085

Figure 2.

Figure 2

(a) Plasma α‐defensins 1–3 (α‐Defs) concentrations in patients with Crohn's disease (CD), non‐CD ileitis and healthy controls. (b) Plasma α‐Defs 4 concentrations in patients with CD, non‐CD ileitis and healthy controls.